Drug Reference
Quick-reference drug tables for cardiology — antiarrhythmic dosing, anticoagulant protocols, heart failure GDMT titration, IV drip calculations, and critical drug-drug interactions.
5 Reference Guides
Each guide includes dosing tables, monitoring parameters, clinical pearls, and key references.
Antiarrhythmic Drugs
Vaughan-Williams classification with dosing, monitoring, and contraindications. Class I-IV agents plus adenosine, digoxin, ivabradine, and ranolazine. Amiodarone toxicity screening schedule and dofetilide renal dosing.
Anticoagulants
DOAC comparison tables with CrCl-based renal dosing for all four agents. Warfarin management, PAUSE trial periprocedural protocols, bridging decisions (BRIDGE trial), reversal agents, and special populations.
Heart Failure GDMT
The four pillars of HFrEF therapy — ARNI/ACEi/ARB, beta-blockers, MRAs, and SGLT2 inhibitors. Starting and target doses from landmark trials, titration schedules, adjunctive therapies, and rapid initiation protocols.
IV Cardiac Drips
Amiodarone, procainamide, ibutilide, and isoproterenol loading protocols. Vasopressor and inotrope comparison tables, anticoagulation infusions, EP lab sedation, and vasodilator drips with hemodynamic effects.
Drug-Drug Interactions
QT-prolonging combinations, antiarrhythmic interactions (amiodarone, dofetilide), DOAC P-gp/CYP3A4 tables, statin dose caps, triple antithrombotic therapy trials, and device-drug interactions.
About This Reference
Drug dosing and interaction tables are based on current FDA labeling, society guidelines, and landmark trial protocols. Always verify doses against institutional formulary and current prescribing information. These are educational resources and are not intended to replace clinical judgment or pharmacy consultation. Full disclaimer →